CAS RN: 1447606-51-0
1A,2,3,7B-TETRAHYDRO-1H-CYCLOPROPA[C]QUINOLINE
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1447606-51-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
1447606-51-0 / 1a,2,3,7b-tetrahydro-1H-cyclopropa[c]quinoline
Standard CAS: 1447606-51-0
Multi CAS: No
Basic Information
copy
CAS
1447606-51-0 copy
Multi CAS
No copy
Molecular Formula
C10H11N copy
Molecular Weight
145.200000 copy
Exact Mass
145.089149 copy
SMILES
C1C2C1C3=CC=CC=C3NC2 copy
InChI
InChI=1S/C10H11N/c1-2-4-10-8(3-1)9-5-7(9)6-11-10/h1-4,7,9,11H,5-6H2 copy
InChIKey
OEHUSLVNUHYNLQ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.4 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
45.78 copy
TPSA
12.03 copy
LogP / Solubility
WLOGP
2.22 copy
MLOGP
1.94 copy
XLogP3
2.1 copy
Consensus LogP
2.09 copy
Log S (ESOL)
-2.54 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.35 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.44 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.03 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy